Presenilins in memory, Alzheimer's disease, and therapy
- PMID: 15091335
- DOI: 10.1016/s0896-6273(04)00218-1
Presenilins in memory, Alzheimer's disease, and therapy
Abstract
Presenilins are considered to be the catalytic subunits of the gamma-secretase complex and are therefore drug targets for Alzheimer's disease. They are also essential for the fine tuning of the immunological system and for memory and synaptic plasticity. Genetic ablation in the forebrain results in a progressive neurodegenerative process that is independent from Abeta generation. The question arises as to what extent these observations should influence our thinking on the pathogenesis of Alzheimer's disease and on strategies to further develop gamma-secretase inhibitors.
Similar articles
-
Presenilins as therapeutic targets for the treatment of Alzheimer's disease.Trends Mol Med. 2001 Jun;7(6):264-9. doi: 10.1016/s1471-4914(01)02064-0. Trends Mol Med. 2001. PMID: 11378516 Review.
-
The presenilins.Genome Biol. 2002 Oct 23;3(11):reviews3014. doi: 10.1186/gb-2002-3-11-reviews3014. Epub 2002 Oct 23. Genome Biol. 2002. PMID: 12429067 Free PMC article. Review.
-
The inhibition of gamma-secretase as a therapeutic approach to Alzheimer's disease.Drug News Perspect. 2004 Jun;17(5):321-5. doi: 10.1358/dnp.2004.17.5.829036. Drug News Perspect. 2004. PMID: 15334182 Review.
-
Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.Nat Cell Biol. 2000 Jul;2(7):428-34. doi: 10.1038/35017062. Nat Cell Biol. 2000. PMID: 10878808
-
gamma-Secretase: characterization and implication for Alzheimer disease therapy.Neurobiol Aging. 2002 Nov-Dec;23(6):1023-30. doi: 10.1016/s0197-4580(02)00126-4. Neurobiol Aging. 2002. PMID: 12470798
Cited by
-
Gamma-secretase-dependent and -independent effects of presenilin1 on beta-catenin.Tcf-4 transcriptional activity.PLoS One. 2008;3(12):e4080. doi: 10.1371/journal.pone.0004080. Epub 2008 Dec 30. PLoS One. 2008. PMID: 19114997 Free PMC article.
-
Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease.EMBO Rep. 2007 Feb;8(2):141-6. doi: 10.1038/sj.embor.7400897. EMBO Rep. 2007. PMID: 17268505 Free PMC article. Review.
-
Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities.Int J Hematol. 2005 Nov;82(4):295-301. doi: 10.1532/IJH97.05096. Int J Hematol. 2005. PMID: 16298817 Review.
-
Presenilin 2 overexpression is associated with apoptosis in Neuro2a cells.Transl Neurosci. 2016 Aug 1;7(1):71-75. doi: 10.1515/tnsci-2016-0011. eCollection 2016. Transl Neurosci. 2016. PMID: 28123824 Free PMC article.
-
Consequences of inhibiting amyloid precursor protein processing enzymes on synaptic function and plasticity.Neural Plast. 2012;2012:272374. doi: 10.1155/2012/272374. Epub 2012 Jun 26. Neural Plast. 2012. PMID: 22792491 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical